Journal of the American Chemical Society · 1998 · 121 citations · 29 references
Bioorganic ChemistryRecombinant αEngineeringGlycobiologyMolecular Biologyα-Galactosyl EpitopesEnzymatic ModificationBiosynthesisProtein ExpressionTwo-step Enzymatic SynthesisAntibody EngineeringHuman SerumGlycosylationXenotransplantationBiochemistryBiocatalysisBioconjugationBiomolecular EngineeringNatural SciencesBiotechnologySynthetic BiologyCarbohydrate-protein Interaction
α-Galactosyl epitopes are carbohydrate structures bearing a Galα1-3Galβ terminus. The interaction of these epitopes on the surface of animal cells with anti-α-galactosyl antibodies in human serum is believed to be the main cause in antibody-mediated hyperacute rejection in xenotransplantation. This report describes an efficient chemoenzymatic approach based on the use of recombinant α(1→3)-galactosyltransferase (α1,3-GalT) for the synthesis of xenoactive α-galactosyl epitopes, which are highly desired in the research of xenotransplantation and immunotherapy. A truncated bovine α1,3-GalT (80−368) was cloned into the pET15b vector and subsequently transformed into E. coli BL21 strain. This expression system efficiently produced the soluble recombinant enzyme on a large scale with highly specific activity. A variety of α(1→3)-galactosylated epitopes were synthesized using such a recombinant enzyme. In a unique fashion, α-galactosyl pentasaccharide was synthesized via a one-pot, two-step enzymatic synthesis with in situ cofactor regeneration.
29
Robert D. Larsen, Valanila P. Rajan, Mark Ruff et al. · Proceedings of the National Academy of Sciences · 1989 · 223 citations · Full text
Chi Huey Wong, Sharon L. Haynie, George M. Whitesides · The Journal of Organic Chemistry · 1982 · 221 citations
Uridine 5'-Diphosphate Galactose, Biosynthesis, Bioorganic Chemistry +14